Research Article

Circulating Th1, Th2, and Th17 Levels in Hypertensive Patients

Table 3

The levels of circulating Th1, Th2, and Th17 cells and their functional cytokines in patients.

Control ()HT ()Dipper ()Nondipper ()NCAP ()CAP ()

Th1 (%)16.28 ± 2.9924.89 ± 3.8822.54 ± 3.2026.77 ± 3.34,§§23.83 ± 3.9026.63 ± 3.18,#
Th2 (%)3.24 ± 0.541.47 ± 0.451.66 ± 0.441.31 ± 0.401.62 ± 0.431.22 ± 0.37,#
Th17 (%)0.88 ± 0.271.49 ± 0.561.20 ± 0.461.72 ± 0.52,§§1.48 ± 0.611.69 ± 0.64
IFN-γ (pg/mL)12.56 ± 2.7618.20 ± 4.4616.43 ± 3.9419.62 ± 4.4217.91 ± 3.9418.68 ± 5.31
IL-4 (pg/mL)28.31 ± 9.1521.46 ± 7.5723.12 ± 7.4620.14 ± 7.5423.22 ± 7.7918.57 ± 6.40
IL-17 (pg/mL)5.84 ± 1.998.16 ± 2.357.37 ± 2.328.79 ± 2.227.68 ± 2.158.94 ± 2.51

Note: the data are given as the mean ± SD. versus control, versus control, § nondipper versus dipper, §§ nondipper versus dipper, and # CAP versus NCAP.